SHORT-TERM CORTICOSTEROID-THERAPY FOR CHRONIC ACTIVE HEPATITIS-B

被引：4

作者：

LASKUS, T ^{[1
]}

CIANCIARA, J ^{[1
]}

LOCH, T ^{[1
]}

SLUSARCZYK, J ^{[1
]}

机构：

[1] INST INFECT & PARASIT DIS,DEPT IMMUNOPATHOL,PL-01201 WARSAW,POLAND

来源：

DIGESTION | 1990年 / 47卷 / 02期

关键词：

HEPATITIS-B; CHRONIC HEPATITIS; CORTICOSTEROIDS;

D O I：

10.1159/000200485

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Seventeen patients with chronic active type B hepatitis were treated with prednisone for 4 weeks. All were initially hepatitis B e antigen (HB(e)Ag)-positive and 14 were DNA-polymerase-positive as well. In the follow-up period of 1 year, 10 patients became persistently negative for DNA polymerase and 11 cleared HB(e)Ag. from serum, while among 17 matched untreated controls only one lost DNA polymerase and HB(e)Ag. However, 1 patient who was initially DNA-polymerase-negative and who lost HB(e)Ag after treatment reactivated to HB(e)Ag after 4 months and DNA polymerase appeared in his serum. He suffered prolonged exacerbation of liver disease after treatment and died of liver failure. Shortterm corticosteroid therapy may be of value in patients with chronic active type B hepatitis, however, in some cases such treatment may be disastrous.

引用

页码：115 / 120

页数：6

共 50 条

[21] FLUCTUATIONS IN VIREMIA, AMINOTRANSFERASES AND IGM ANTIBODY TO HEPATITIS-B CORE ANTIGEN IN CHRONIC HEPATITIS-B PATIENTS WITH DISEASE EXACERBATIONS [J].

MELS, GC ;

BELLATI, G ;

LEANDRO, G ;

BRUNETTO, MR ;

VICARI, O ;

BORZIO, M ;

PIANTINO, P ;

FORNACIARI, G ;

SCUDELLER, G ;

ANGELI, G ;

BONINO, F ;

IDEO, G .

LIVER, 1994, 14 (04) :175-181

[22] Short-Term Versus Long-Term Systemic Corticosteroid Use in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients [J].

Alshehri, Samah ;

Alalawi, Mai ;

Makeen, Abdulrahman ;

Jad, Ammar ;

Alhuwaysi, Ahmed ;

Alageeli, Mohammed ;

Alshibani, Mohannad .

MALAYSIAN JOURNAL OF MEDICAL SCIENCES, 2021, 28 (01) :59-65

[23] DETECTION OF PRE-C AND CORE REGION MUTANTS OF HEPATITIS-B VIRUS IN CHRONIC HEPATITIS-B VIRUS CARRIERS [J].

WAKITA, T ;

KAKUMU, S ;

SHIBATA, M ;

YOSHIOKA, K ;

ITO, Y ;

SHINAGAWA, T ;

ISHIKAWA, T ;

TAKAYANAGI, M ;

MORISHIMA, T .

JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (06) :1793-1801

[24] MEMBRANE STAINING FOR HEPATITIS-B SURFACE-ANTIGEN ON HEPATOCYTES - A SENSITIVE AND SPECIFIC MARKER OF ACTIVE VIRAL REPLICATION IN HEPATITIS-B [J].

CHU, CM ;

LIAW, YF .

JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (05) :470-473

[25] Antiviral therapy of chronic hepatitis B [J].

Zoulim, Fabien .

ANTIVIRAL RESEARCH, 2006, 71 (2-3) :206-215

[26] Antiviral Therapy for Chronic Hepatitis B [J].

Lee, Kwan Sik .

JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2009, 52 (08) :831-837

[27] PROSPECTIVES ON THE TREATMENT OF CHRONIC HEPATITIS-B AND CHRONIC HEPATITIS-C WITH THYMIC PEPTIDES AND ANTIVIRAL AGENTS [J].

MUTCHNICK, MG ;

EHRINPREIS, MN ;

KINZIE, JL ;

PELEMAN, RR .

ANTIVIRAL RESEARCH, 1994, 24 (2-3) :245-257

[28] EFFECTIVENESS OF ADENINE-ARABINOSIDE 5'-MONOPHOSPHATE IN KIDNEY-TRANSPLANT RECIPIENTS WITH CHRONIC ACTIVE HEPATITIS-B [J].

POL, S ;

SALTIEL, C ;

LEGENDRE, C ;

CARNOT, F ;

DRISS, F ;

BERTHEOLT, P ;

BRECHOT, C ;

RUET, C ;

KREIS, H .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 1994, 9 (07) :820-823

[29] Fatal Lactic Acidosis Associated With Tenofovir Therapy for Chronic Active Hepatitis B Infection [J].

Mckeever, Rita ;

Surmaitis, Ryan ;

Vearrier, David ;

Greenberg, Michael .

CLINICAL TOXICOLOGY, 2016, 54 (08) :745-745

[30] Long-term systemic corticosteroid-therapy associated measures: Description of the French internal medicine physicians' practices [J].

Fardet, L. ;

Hanslik, T. ;

Blanchon, T. ;

Perdoncini-Roux, A. ;

Kettaneh, A. ;

Tiev, K. P. ;

Turbelin, C. ;

Dorleans, Y. ;

Cabane, J. .

REVUE DE MEDECINE INTERNE, 2008, 29 (12) :975-980

← 1 2 3 4 5 →